Arcadia Biosciences Inc.
(RKDA)
undefined
undefined%
At close: undefined
Company Description
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States.
It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications.
The company was incorporated in 2002 and is headquartered in Davis, California.
Arcadia Biosciences Inc.
| Country | United States |
| IPO Date | May 15, 2015 |
| Industry | Agricultural Inputs |
| Sector | Basic Materials |
| Employees | 21 |
| CEO | Thomas J. Schaefer C.F.A. |
Contact Details
Address: 202 Cousteau Place Davis, California United States | |
| Website | https://www.arcadiabio.com |
Stock Details
| Ticker Symbol | RKDA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001469443 |
| CUSIP Number | 039014204 |
| ISIN Number | US0390143032 |
| Employer ID | 81-0571538 |
| SIC Code | 0100 |
Key Executives
| Name | Position |
|---|---|
| Thomas J. Schaefer C.F.A. | Chief Executive Officer, President & Director |
| Mark Kawakami | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 11, 2024 | 425 | Filing |
| Dec 11, 2024 | 8-K | Current Report |
| Dec 06, 2024 | 425 | Filing |
| Dec 06, 2024 | 8-K | Current Report |
| Nov 22, 2024 | S-8 | Filing |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Aug 23, 2024 | 8-K/A | [Amend] Current Report |
| Aug 21, 2024 | 4 | Filing |
| Aug 21, 2024 | 4 | Filing |